10-Q: Ensign Group Reports Strong Q2 2026 Growth
Quarterly Report
The Ensign Group, Inc. (ENSG) announced robust Q2 2026 results, with total revenue up 17.3% year-over-year, driven by strong occupancy and strategic acquisitions.
Summary
- The Ensign Group, Inc. reported a 17.3% increase in total revenue for the three months ended June 30, 2026, reaching $1.44 billion, compared to $1.23 billion in the same period last year.
- Net income attributable to the company grew by 18.2% to $99.7 million, or $1.68 per diluted share, up from $84.4 million, or $1.44 per diluted share, in Q2 2025.
- Skilled services revenue increased by 17.6% to $1.38 billion, driven by a 2.0% increase in overall occupancy to 82.9% and a higher skilled mix.
- Standard Bearer, the company's REIT segment, saw rental revenue increase by 40.2% to $44.1 million.
- The company repurchased $40 million of its common stock during the quarter as part of an expanded $100 million repurchase program.
- Acquisitions contributed significantly, with recently acquired facilities adding $133.5 million in revenue for the quarter.
- The company ended the quarter with $262.3 million in cash and cash equivalents.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this filing positively due to strong revenue growth, improved occupancy, and effective acquisition integration, indicating solid operational performance and strategic execution.
Positives
- Total revenue increased by 17.3% to $1.44 billion for the three months ended June 30, 2026.
- Net income attributable to Ensign Group increased by 18.2% to $99.7 million.
- Diluted EPS grew by 16.7% to $1.68.
- Skilled services revenue rose 17.6% to $1.38 billion.
- Overall occupancy improved by 2.0% to 82.9%.
- Standard Bearer segment rental revenue increased by 40.2%.
- The company repurchased $40 million of its common stock, with $60 million remaining under its repurchase program.
- Acquisitions contributed $133.5 million in revenue for the quarter.
Negatives
- General and administrative expenses increased by 24.3% to $85.9 million, partly due to system implementation costs.
- Depreciation and amortization expense increased by 21.8% to $31.4 million, primarily due to new acquisitions.
- The company's effective tax rate increased to 25.3% from 24.8% in the prior year period.
Risks
- Changes in Medicare and Medicaid reimbursement rates, rules, and spending requirements could adversely affect revenue and results of operations.
- Increased competition for nurses and skilled personnel could raise labor costs and lead to staffing shortages.
- Potential for increased government reviews, audits, and investigations, which could result in fines, penalties, or loss of participation in government programs.
- Cybersecurity incidents and data breaches could lead to significant liability and reputational damage.
- Failure to comply with extensive and complex healthcare laws and regulations could require significant expenditures or operational changes.
- The company's geographic concentration in Arizona, California, and Texas makes it vulnerable to regional economic downturns or regulatory changes.
- Lease obligations and debt covenants could restrict business activities and lead to defaults if not met.
- Litigation and potential for large settlement amounts or damage awards pose a risk to financial condition and results of operations.
Future Outlook
The company's strategy of acquiring, integrating, and improving operations, combined with investments in people and a disciplined operating model, positions it for sustained long-term growth. Management believes its current cash, investments, projected operating cash flows, and available financing will support normal business operations for the foreseeable future.
Management Comments
- Our results serve as a strong indicator that our strategy is working and our transformation is underway.
- Our dedication to our cultural and fundamental operational principles continues to deliver strong results.
- Despite seasonal trends, both metrics exceeded our expectations, reflecting the strength of our clinical programs, local leadership teams, and disciplined operating model.
- The resulting period over period progress demonstrates our continued execution on targeted initiatives related to increasing occupancy and the level of acuity and complexity of the patients we serve in our facilities.
Industry Context
StockSavvy.ai notes that Ensign Group's performance reflects a strong operational environment within the post-acute care sector, characterized by increasing patient acuity and a strategic focus on acquisitions and operational improvements. The company's ability to grow revenue and occupancy in a competitive landscape highlights effective management of its portfolio.
Comparison to Industry Standards
- Ensign Group's occupancy rate of 82.9% for skilled services in Q2 2026 exceeds the industry average, which typically hovers in the mid-to-high 70s.
- The company's skilled mix revenue percentage of 50.0% indicates a favorable patient acuity profile compared to many peers who may have a higher proportion of lower-reimbursed Medicaid patients.
- The 17.3% year-over-year revenue growth is robust, outperforming the general healthcare services sector growth rates.
- The company's strategic acquisitions and integration capabilities are a key differentiator, allowing it to expand market share and improve underperforming assets, a strategy not universally adopted or as effectively executed by all competitors.
Legal Proceedings
- The company is involved in various legal actions and administrative proceedings, including claims related to wage and hour laws, and potential violations of healthcare regulations.
- A derivative complaint was filed on July 16, 2026, against certain current and former directors and officers, alleging breach of fiduciary duty and unjust enrichment related to compliance, staffing, compensation, and related-party transactions.
- The company is cooperating with a DOJ Civil Investigative Demand (CID) regarding claims submitted to Medicare and Texas Medicaid for unnecessary services.
- A lawsuit filed in California against OHCA seeks to declare CMIR regulations unconstitutional and void as applied to the company, challenging a subpoena related to a proposed transaction.
Related Party Transactions
- Intercompany rental revenue generated from Ensign affiliated operations was $37,785,000 and $68,617,000 for the three and six months ended June 30, 2026, respectively.
- Management fees generated between Standard Bearer and the Service Center were $2,646,000 and $4,809,000 for the three and six months ended June 30, 2026, respectively.
- Interest expense from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. was $14,149,000 and $23,916,000 for the three and six months ended June 30, 2026, respectively.
Stakeholder Impact
- Shareholders benefit from strong revenue growth, increased net income, and a significant stock repurchase program.
- Employees may see continued investment in training and development, but also face potential impacts from labor market dynamics and unionization efforts.
- Patients and residents are expected to benefit from improved occupancy and a focus on higher acuity care, though regulatory changes could impact service availability or cost.
- Lenders and creditors are supported by the company's strong cash flow and compliance with debt covenants.
- Suppliers may experience increased business due to the company's expansion, but could also face challenges related to potential supply chain disruptions and inflation.
Next Steps
- Continue to integrate and improve recently acquired facilities.
- Monitor and adapt to evolving Medicare and Medicaid regulations and reimbursement policies.
- Execute on the $100 million stock repurchase program.
- Focus on maintaining and improving quality of care ratings.
- Manage labor costs and address potential staffing shortages.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | End of fiscal year for prior period comparison. |
| 2026-01-01 | Beginning of the six-month period for financial reporting. |
| 2026-04-01 | Beginning of the second quarter of fiscal year 2026. |
| 2026-05-13 | Board of Directors approved a stock repurchase program. |
| 2026-06-10 | Director Barry M. Smith terminated his Rule 10b5-1 trading arrangement. |
| 2026-06-12 | Board of Directors amended the stock repurchase program. |
| 2026-06-30 | End of the second quarter and six-month period for financial reporting. |
| 2026-07-27 | Date of filing the Form 10-Q. |
Recommendation
buyThe Ensign Group demonstrates strong financial performance with significant revenue growth, improved operational metrics like occupancy and skilled mix, and effective execution of its acquisition strategy. The company's robust cash flow, ongoing stock repurchase program, and positive industry positioning suggest continued value creation for shareholders, warranting a buy recommendation.
Keywords
Skilled Nursing Facilities, Healthcare Services, Post-Acute Care, REIT, Acquisitions, Occupancy Rates, Medicare Reimbursement, Medicaid Reimbursement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.